Zacks Investment Research cut shares of Hanger (OTCMKTS:HNGR) from a buy rating to a hold rating in a research report sent to investors on Friday.
According to Zacks, “Hanger, Inc. delivers orthotic and prosthetic patient care, and distributes O&P products and rehabilitative solutions. The company’s products & services segment provides Hanger distributes branded and private label O&P devices, products and components and provides rehabilitative solutions. Hanger Inc., formerly known as Hanger Orthoped, is based in AUSTIN, Texas. “
A number of other equities research analysts have also issued reports on the stock. ValuEngine raised shares of Hanger from a buy rating to a strong-buy rating in a report on Saturday, February 3rd. Stephens set a $17.00 price objective on shares of Hanger and gave the company a hold rating in a report on Monday, January 22nd.
TRADEMARK VIOLATION NOTICE: This piece of content was published by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3342134/hanger-hngr-downgraded-to-hold-at-zacks-investment-research.html.
Hanger, Inc provides orthotic and prosthetic (O&P) patient care services; and distributes O&P devices, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates in two segments, Patient Care and Products & Services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hanger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanger and related companies with MarketBeat.com's FREE daily email newsletter.